Search by Drug Name or NDC

NDC 70954-0409-10 Sildenafil Citrate 100 mg/1 Details

Sildenafil Citrate 100 mg/1

Sildenafil Citrate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is SILDENAFIL CITRATE.

MedlinePlus Drug Summary

Sildenafil (Viagra) is used to treat erectile dysfunction (impotence; inability to get or keep an erection) in men. Sildenafil (Liqrev, Revatio) is used to improve the ability to exercise in adults (Liqrev, Revatio) and children 1 year of age and older (Revatio) with pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Sildenafil is in a class of medications called phosphodiesterase (PDE) inhibitors. Sildenafil treats erectile dysfunction by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Sildenafil treats PAH by relaxing the blood vessels in the lungs to allow blood to flow easily. If you are taking sildenafil to treat erectile dysfunction, you should know that it does not cure erectile dysfunction or increase sexual desire. Sildenafil does not prevent pregnancy or the spread of sexually transmitted diseases such as human immunodeficiency virus (HIV).

Related Packages: 70954-0409-10
Last Updated: 05/12/2024
MedLinePlus Full Drug Details: Sildenafil

Product Information

NDC	70954-0409
Product ID	70954-409_6d8dbaa6-d61a-46ae-a641-f664104f4714
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Sildenafil Citrate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Sildenafil Citrate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	100
Active Ingredient Units	mg/1
Substance Name	SILDENAFIL CITRATE
Labeler Name	ANI Pharmaceuticals, Inc.
Pharmaceutical Class	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA216383
Listing Certified Through	2024-12-31

Package

NDC 70954-0409-10 (70954040910)

Pricing Information	N/A
NDC Package Code	70954-409-10
Billing NDC	70954040910
Package	30 TABLET in 1 BOTTLE (70954-409-10)
Marketing Start Date	2023-08-29
NDC Exclude Flag	N